Skip to main content
Clinical Trials/NCT03486756
NCT03486756
Completed
Not Applicable

Internet-delivered Cognitive Behavior Therapy for Asthma-related Anxiety: A Feasibility Study

Karolinska Institutet1 site in 1 country30 target enrollmentApril 16, 2018
ConditionsAsthma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Asthma
Sponsor
Karolinska Institutet
Enrollment
30
Locations
1
Primary Endpoint
Catastrophizing about asthma Scale
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This is a study to investigate acceptability and feasibility of a novel protocol on exposure-based CBT for asthma-related fear delivered over the Internet (Internet-CBT).

Detailed Description

Asthma is one of the most common chronic diseases around the world, with a high prevalence of anxiety disorders. In a prior study (ClinicalTrials.gov ID: NCT03158194) a protocol for exposure-based CBT was developed for asthma-related anxiety. The aim of the current study is to evaluate acceptability and feasibility of our protocol for asthma-related fear when delivered over the Internet (Internet-CBT). The plan is to include 30 participants that will all receive the intervention in this uncontrolled feasibility study.

Registry
clinicaltrials.gov
Start Date
April 16, 2018
End Date
April 25, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Catarina Almqvist Malmros

Professor

Karolinska Institutet

Eligibility Criteria

Inclusion Criteria

  • asthma diagnosed by a physician
  • anxiety or stress related to asthma

Exclusion Criteria

  • severe psychiatric disorder
  • chronic obstructive pulmonary disease (COPD) and other chronic airway disorders other than asthma

Outcomes

Primary Outcomes

Catastrophizing about asthma Scale

Time Frame: Baseline to 8 weeks; baseline to 16 weeks; baseline to 24 weeks.

Change in catastrophizing cognitions about asthma measured with a self-rating scale at baseline, 8 weeks, 16 weeks and 24 weeks for analysis of effect.

Secondary Outcomes

  • Penn State Worry Questionnaire(Baseline to 8 weeks; baseline to 16 weeks; baseline to 24 weeks.)
  • Asthma control test(Baseline to 8 weeks; baseline to 16 weeks; baseline to 24 weeks.)
  • Perceived Stress Scale(Baseline to 8 weeks; baseline to 16 weeks; baseline to 24 weeks.)
  • Asthma Quality of Life Questionnaire(Baseline to 8 weeks; baseline to 16 weeks; baseline to 24 weeks.)
  • Short Health Anxiety Inventory (SHAI)(Baseline to 8 weeks; baseline to 16 weeks; baseline to 24 weeks.)

Study Sites (1)

Loading locations...

Similar Trials